Eagle Bay Advisors’s Cardiff Oncology CRDF Stock Holding History

Eagle Bay Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-339	Closed	-$1.47K	–	296
2024 Q4	$1.47K	Hold	339	–	–	﹤0.01%	915
2024 Q3	$905	Hold	339	–	–	﹤0.01%	1293
2024 Q2	$753	Hold	339	–	–	﹤0.01%	948
2024 Q1	$1.81K	Hold	339	–	–	﹤0.01%	888
2023 Q4	$502	Hold	339	–	–	﹤0.01%	803
2023 Q3	$471	Hold	339	–	–	﹤0.01%	819
2023 Q2	$498	Hold	339	–	–	﹤0.01%	814
2023 Q1	$559	Hold	339	–	–	﹤0.01%	864
2022 Q4	$475	Hold	339	–	–	﹤0.01%	887
2022 Q3	$1K	Hold	339	–	–	﹤0.01%	814
2022 Q2	$746	Buy	+339	New	+$568	﹤0.01%	954
2022 Q1	–	Sell	-339	Closed	-$2K	–	438
2021 Q4	$2K	Hold	339	–	–	﹤0.01%	901
2021 Q3	$2K	Hold	339	–	–	﹤0.01%	927
2021 Q2	$3K	Buy	+339	New	+$2.88K	﹤0.01%	788

Other funds holding CRDF

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

William Blair & Company

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return